BMC Geriatrics

unofficial impact factor 1.70
Search for
Advanced search
BMC Geriatrics
Tools
Share this article
Open Access Email this article to a friend

Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis

Jaime Caro*, Denis Getsios, Kristen Migliaccio-Walle, Jack Ishak, Wissam El-Hadi and for the AHEAD Study Group

BMC Geriatrics 2003, 3:6 doi:10.1186/1471-2318-3-6

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.